We are live on
!
Find out more
Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$180B
1-Year Est. Return
37.51%
This Fund
S&P 500
This Quarter
Est. Return
-5.23%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$31.1B
AUM Growth
+$8.47B
(+37%)
Cap. Flow
+$10.9B
Cap. Flow
% of AUM
35.15%
Top 10 Holdings %
Top 10 Hldgs %
26.71%
Holding
1,155
New
13
Increased
800
Reduced
137
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$917M |
| 2 |
Visa
V
|
+$671M |
| 3 |
Philip Morris
PM
|
+$570M |
| 4 |
Danaher
DHR
|
+$543M |
| 5 |
Accenture
ACN
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$70.5M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$11M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$7.66M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.55M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$5.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.53% |
| 2 | Healthcare | 19.02% |
| 3 | Financials | 12.43% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Consumer Staples | 8.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
BridgeBio Pharma
BBIO
$16.4B
| $247K | ﹤0.01% |
24,878
+1,613
| +7% | +$16.8K |
|
1002
RLX Technology
RLX
$2.42B
| $241K | ﹤0.01% |
229,815
| – | – |
|
|
BFS
1003
Saul Centers
BFS
$853M
| $240K | ﹤0.01% |
6,398
+1,200
| +23% | +$55.3K |
|
1004
Immersion
IMMR
$248M
| $240K | ﹤0.01% |
43,691
-1,921
| -4% | -$10.8K |
|
|
CLDT
1005
Chatham Lodging
CLDT
$580M
| $237K | ﹤0.01% |
23,963
+3,900
| +19% | +$46.9K |
|
1006
Marathon Digital Holdings
MARA
$3.74B
| $235K | ﹤0.01% |
21,945
+678
| +3% | +$8.03K |
|
|
ONL
1007
Orion Office REIT
ONL
$158M
| $235K | ﹤0.01% |
26,819
| – | – |
|
1008
Twist Bioscience
TWST
$7.72B
| $234K | ﹤0.01% |
6,633
-19
| -0.3% | -$807 |
|
1009
Arrowhead Research
ARWR
$12.6B
| $233K | ﹤0.01% |
7,053
-35
| -0.5% | -$1.41K |
|
|
UBA
1010
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $226K | ﹤0.01% |
14,569
| – | – |
|
1011
Riot Platforms
RIOT
$7.65B
| $225K | ﹤0.01% |
32,141
+1,755
| +6% | +$12.4K |
|
1012
Inovio Pharmaceuticals
INO
$79.1M
| $221K | ﹤0.01% |
10,671
+129
| +1% | +$3.3K |
|
1013
Ultragenyx Pharmaceutical
RARE
$2.66B
| $219K | ﹤0.01% |
5,288
+9
| +0.2% | +$462 |
|
1014
AbCellera Biologics
ABCL
$2.98B
| $216K | ﹤0.01% |
21,866
+9
| +0% | +$99 |
|
1015
Vericel Corp
VCEL
$2.27B
| $211K | ﹤0.01% |
9,088
+41
| +0.5% | +$1.12K |
|
|
AZRE
1016
DELISTED
Azure Power Global Limited
AZRE
| $210K | ﹤0.01% |
37,863
-5,210
| -12% | -$48K |
|
1017
Ionis Pharmaceuticals
IONS
$9.21B
| $208K | ﹤0.01% |
4,708
+314
| +7% | +$13.2K |
|
1018
Arcturus Therapeutics
ARCT
$214M
| $206K | ﹤0.01% |
13,915
| – | – |
|
|
BHIL
1019
DELISTED
Benson Hill, Inc.
BHIL
| $205K | ﹤0.01% |
2,136
+43
| +2% | +$4.73K |
|
|
ALX
1020
Alexander's
ALX
$1.39B
| $204K | ﹤0.01% |
974
| – | – |
|
1021
Workiva
WK
$3.76B
| $203K | ﹤0.01% |
2,607
+241
| +10% | +$16.5K |
|
|
SAFE
1022
DELISTED
Safehold Inc.
SAFE
| $201K | ﹤0.01% |
7,582
+1,681
| +28% | +$65.5K |
|
1023
BioNTech
BNTX
$23.3B
| $200K | ﹤0.01% |
1,486
-13
| -0.9% | -$1.99K |
|
1024
Ocugen
OCGN
$465M
| $200K | ﹤0.01% |
112,627
+1,955
| +2% | +$4.87K |
|
|
EVOP
1025
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $195K | ﹤0.01% |
5,852
+227
| +4% | +$7.01K |
|
Similar funds
VGA
Mitsubishi UFJ Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Mitsubishi UFJ Asset Management held 1,155 positions worth $31.1B, up 37% from $22.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Mitsubishi UFJ Asset Management deployed $10.9B of net new capital in Q3 2022, opening 13 new positions and adding to 800 existing holdings. Its largest new stake was Shockwave Medical, Inc. Common Stock: 34,960 shares worth $9.72M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares MBS ETF, an estimated $70.5M trimmed.
- Mitsubishi UFJ Asset Management's largest Q3 2022 buy was Shockwave Medical, Inc. Common Stock: 34,960 shares worth $9.72M.
- Mitsubishi UFJ Asset Management added most to Microsoft in Q3 2022, an estimated $917M increase.
- Mitsubishi UFJ Asset Management's biggest Q3 2022 reduction was iShares MBS ETF, cutting an estimated $70.5M.
- Mitsubishi UFJ Asset Management fully exited American Campus Communities, Inc. in Q3 2022, selling an estimated $4M.
- Mitsubishi UFJ Asset Management's ten largest holdings make up 27% of its $31.1B portfolio in Q3 2022.
- Mitsubishi UFJ Asset Management opened 13 new positions and closed 24 in Q3 2022.
- Mitsubishi UFJ Asset Management's portfolio value rose 37% quarter-over-quarter to $31.1B.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2022, filed 1 Nov 2022.